Abstract
The U.S. market accounts for the largest share of global revenues for small
joint implants. Growth will be influenced by the adoption of products that
have only been available overseas, the preference for motion-preserving
technologies over fusion, and challenges with respect to reimbursement and
regulatory factors.
New product introductions could have a significant impact on the U.S. market.
Reverse shoulder replacements have recently become available, which expand the
treatable population to include individuals with severe rotator cuff damage.
Renewed interest in ankle replacements and the potential introduction of the
first mobile-bearing devices in the U.S. could result in a shift towards ankle
replacements over fusions in selected patients.
While challenges with respect to reimbursement and healthcare costs will have
an impact on revenues, sales growth is expected to remain strong through 2015
due to the rising prevalence of conditions that affect the small joints. This
report examines the market for replacement, fixation, and fusion implants for
the shoulder, elbow, wrist, fingers, ankle and foot, and provides a detailed
analysis of the clinical and economic factors driving the market.
| 
View Cart
